Share this article

Exufiber® and Exufiber® Ag+: A review of the scientific and clinical evidence

Amit Gefen, Erik Carlsson, John Timmons, Kristina Hamberg, Mats Wendel, Sara Rook
5 September 2021

Wound dressings have been created to manage a number of clinical conditions, including cavity wounds and wounds where exudate levels may vary from low levels in a relatively dry wound to highly exuding wounds where there is a genuine risk of damage to the surrounding skin. The evidence included in this supplement highlights some of the key pre-clinical and clinical studies conducted to evaluate the performance of Exufiber and Exufiber Ag+ gelling fibre dressings.

Free for all healthcare professionals

Sign up to the Wounds Group journals

By clicking ‘Subscribe’, you are agreeing that the Wounds Group are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our privacy policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.

I am not a healthcare professional.